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Up to a  recent date two sources  of antipoliomyelitie serum  have 
been known: one, human beings who have recovered from attacks of 
poliomyelitis irrespective of their severity; and the  other, monkeys 
experimentally inoculated with the virus of the  disease.  Monkeys, 
like human beings, were found to yield a  virus neutralizing  serum, 
not only when they developed symptoms, usually paralytic, of polio- 
myelitis, but also when they were actively ~rnmurdzed with subclinical 
doses of the virus itself.  There is reason to believe that  such sub- 
clinical immunization takes  place  in  human  beings,  perhaps  on  a 
large scale, during epidemic  prevalences of poliomyelitis. 
The knowledge s,!mmarized in this brief statement is based on the investigation 
carried out in 1910 and since then (Flexner and Lewis (1), Roemer and Joseph (2), 
Landsteiner and Levaditi (3), Zappert, yon Wiesner, and Leiner (4), Anderson and 
Frost (5), Amossand Chesney (6), and Aycock and Kagan (7)).  In 1910, Flexner 
and Lewis  (9) determined definitely,  by monkey experiment, that convalescent 
monkey and human sera possessed  therapeutic properties.  Netter  (8)  was the 
first to apply this knowledge  to the treatment of human cases of poliomyelitis. 
The experiments of Flexner and Lewis (9), carried out with potent virus inoculated 
intracerebrally, indicated that with a  minimal but effective dose of virus, and 
several intrathecal injections of convalescent serum begun  24 hours after the 
inoculation, prevention of paralysis or other symptoms of poliomyelitis could be 
secured.  In  the years  intervening between  1910 and  the  present  time,  con- 
valescent human serum has been widely employed in the treatment of early cases 
of poliomyelitis  in man with beneficial results,  so far as clinical  and statistical 
indications can be interpreted. 
Attempts  were early made by several experimenters  to  produce a 
virus neutralizing serum in animals other than monkeys. 
Flexner (10) in  1910 reported negative results with horse,  goat, and several 
kinds of small laboratory animals.  Sheep alone yielded inactivating substances. 
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But these substances existed in the blood of normal sheep and appeared not to be 
increased by immunization.  The  method  usually  followed was  to  inject  sus- 
pensions of the central nervous organs of monkeys succumbing to acute experi- 
mental  poliomyelitis.  One or two exceptions to the common experience were 
recorded.  Neust~dter and Banzhaf (11) (1917) believed that they had produced 
in a horse substances definitely inactivating  to the virus when combined in d~ro. 
Pettit  (12) (1918) produced both in the horse and  the sheep, neutralizing  sera 
which have had considerable clinical employment in France.  Recently Weyer, 
Park  and  Banzhaf  (13) and  Fairbrother  (14) have  reported  more  significant 
successes with the horse.  The former found that the inactivating substances in 
the serum could be concentrated in the globulin fraction. 
Through  the kindness of Dr. Park,  a  quantity of  antipoliomyelitic 
horse  serum  has  been  made  available  to  us  for  study.  We  have 
carried through two series of experiments with this serum:  inactivating 
effects in one in vitro and in the other in ~ivo have been investigated. 
It still remains to be determined  whether the biological processes in 
both kinds  of inactivation  or neutralization  are  the  same;  and  it is 
still  an  open  question  whether  the  inactivation  which  occurs  with 
horse  or  sheep  antipoliomyelitic  serum  is  both  qualitatively  and 
quantitatively identical with that produced with convalescent human 
and monkey serum. 
Considerable diversity of view exists with reference to the neutral- 
izing  power  and  process  of  these  alien  sera.  Rosenow  (15)  and 
Nuzum  (16)  early  claimed  to  have  produced  antiviral  sera  in  the 
horse by immunization  with streptococci.  Amoss and Eberson  (17), 
using  serum  supplied  by the  experimenters  named,  were unable  to 
confirm  this  work.  Stewart  and  Haselbauer  (18)  studied  Pettit's 
antipoliomeylitic horse serum and found that it is occasionally virus 
neutralizing.  They also found normal sheep serum to be sometimes 
inactivating,  and  reported  that  sheep yielding  this  serum  when 
subjected to subsequent immunization not only failed to give a more 
potent serum, but occasionally lost the power of inactivation originally 
possessed. 
Obviously,  therefore,  the  nature  of  the  inactivating  process  as 
exhibited  by the  antipoliomyelitic horse or sheep  serum is worthy of 
more minute study.  It is desirable also to employ a virus of definite 
and certain activity and preferably, we believe, a virus which possesses 
these  powers when  used  as  a  filtrate  rather  than  as  suspension  or C.  P.  RHOADS  125 
emulsion.  The very active filtrates are more constant in their effects, 
and the effective dose can be more closely regulated.  It is self-evident 
that the contact between serum and filtrate virus will be more intimate 
than  between  serum  and  emulsion virus,  in  which  relatively large 
particles of nervous tissues must be penetrated. 
Small differences in incubation period in  the inoculated monkeys 
cannot be regarded as significant.  Any large series of virus inoculated 
monkeys will show disparities of this kind, even when intracerebral 
injection  is  employed.  This  is  to  be  expected,  since  the  native 
resistance of the  animals to  a  fixed inoculum varies within certain 
limits.  Flexner and Lewis (19) (1910) pointed out that with a given 
virus,  four  kinds  of  inoculation  effects  could  be  distinguished: no 
discernible  symptoms  of  disease;  abortive  poliomyelitis;  paralytic 
poliomyelitis on  about  the  10th  day;  and  delayed paralytic polio- 
myelitis in which the first symptoms appeared on about the 15th day. 
The  first  two  conditions were  distinguishable on reinoculation: the 
abortive  animals  resisted;  the  symptomless animals reacted  to  the 
second inoculation,  in rare instances, paralytic effects appeared as 
late as the 28th day.  Hence 1 month was always permitted to elapse 
before the experiment was considered  concluded. 
EXPERIMENTAL 
In the experiments to be recorded the highly potent filtrate virus "M.V." has 
been employed.  Injections were made into Maca~us rhesus alone.  The anti- 
poliomyelific horse sera kindly supplied by Drs. Park and Weyer consisted of 
unpreserved horse serum, citrated  horse plasma, and  concentrated  globulin 
fraction.  The controls employed consisted of normal horse serum, citrated horse 
plasma, and the globulin fraction of diphtheria antitoxin.  All inoculations  which 
entailed surgical procedures were carried out under ether anesthesia. 
Experlme~t/.--This test is an exact duplicate of tests frequently made with 
convalescent human and monkey sera.  The virus filtrate, consisting  of 0.3 cc., is 
mixed with serum 0.9 cc., incubated at 37°C. for 2 hours, allowed to stand over 
night  in  the  icebox, and  the whole is  injected  intracerebrally.  Under these 
circumstances, the immune sera neutralize the virus, while the normal horse and 
strictly normal human sera do not. 
Three monkeys were employed: one received normal, unpreserved horse serum 
(control), and the other  two received the unpreserved anfipoliomyelitic horse 
serum.  The inoculations were intracerebral.  Table I  gives the results.  The 
control animal became paralyzed on the 9th day; the two animals receiving the 
antipoliomyelitic  horse serum remained free of all symptoms. 126  HORSE  ANTIPOLIOMYELITIC  SERUM 
Comment.--Taken by itself, this in vitro  experiment has reproduced 
the usual experience  with convalescent human and monkey sera. 
Experiment 2.--This test was an orienting one, designed to indicate the limits of 
effectiveness  possessed  by  the  antipoliomyelitic horse  plasma.  Consequently 
TABLE  I 
Experiment 1.  Unpreserved  Antipoliomyditic Horse, Serum 
No.  Date 
1  ]5/20 
Material tested 
Unfiltered, unpreserved anti- 
poliomyelitic  serum 
Normal,  unpreserved  horse 
serum 
I  ...  s  [ Route 
aount  Villi .  of ino¢ 
am¢ unt  ule ti(~ 
CC.  CC • 
0.9  0.3  Icer.  ] 
0.9  0.3  "  I 
0.9 
Results 
No symptoms 
I 
0.3  t  "  I Typical poliomye- 
I  [  litis on 9th day 
TABLE  II 
Experiment 2.  Antipoliomyditic Horse Plasma 
No.  Date 
1  8/23 
2  8/23 
3  8/2~ 
4  8/2~ 
5  8/2~ 
Material tested 
Normal  horse  serum. 
Control 
Normal  horse  plasma. 
Control 
Antipoliomyelitic horse 
plasma 
tc 
gg 
Virus 
zt  amount 
filtrate 
C~. 
0.01 
0.01 
0.06 
0.12 
0.18 
Result 
Typical poliomyelitis,  20 
days 
No symptoms 
Mild symptoms, 12 days 
No symptoms 
Typical poliomyelitis, 4 
days 
the volume of infecting filtrate was varied widely, and the relations between virus 
and plasma were so arranged as to comply as closely as possible with the technique 
used by Park and Weyer.  The virus calculated on its usual activity represented c.  e.  PJIO.~DS  127 
12 to 36 infecting doses.  The controls consisted of normal ho~se plasma and 
serum. 
Com~enl.--As Table II shows, normal horse plasma is effective in 
preventing infection under conditions in which normal horse serum 
has no final effect.  On the other hand, in one of three monkeys the 
antipoliomyelitic horse  plasma  was  protective  against  at  least  12 
TABLE  III. 
Experiment  2.  Effect of 1.5 Per Cent Cilrage on Poliomyelitis  Virus 
No.  Date 
8/2: 
8/2: 
L0/ll 
LO/I( 
LO/I', 
LO/ll 
L1/1 
L1/1 
Material tested 
Citrated horse plasma 
Undtrated horse serum 
Citrated horse plasma 
Uncltrated horse serum 
Citrated horse serum 
Uncitrated horse serum 
Citrated horse plasma 
Control virus alone 
Virus 
mount 
c,c. 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
Test 
material 
amount 
cc. 
0. I 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
Result 
No symptoms 
Typical poliomyelitis, 19 
days 
Mild  poliomyelitis,  9 
days 
Typical poliomyelitis,  5 
days 
No symptoms 
Typical poliomyelitis,  6 
days 
No symptoms 
Typical poliomyelitis,  7 
days 
M.L.D. of virus, and ineffective against 6 and 18 M'.L.D.  The incubation 
period of the monkey receiving normal horse serum was somewhat 
prolonged,  the  reason  for  which  is  wholly  conjectural.  Since  the 
citrate itself may have exerted an inhibitory effect, a  set of tests was 
carried out to determine this point.  The result is given in Table III 
and can be summarized by the simple statement that sodium citrate in 
concentration of 1.5 per cent does exert an inhibitory chemical effect 
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Experiment Y--This test was made with the globulin concentrate, and controlled 
with normal horse plasma and antipoliomyelitic horse plasma, 2 •.L.D.  of virus 
being employed in each test.  The results are given in Table IV. 
Comment.--Under  the conditions of the experiment, all the  anti- 
poliomyelitic horse preparations inactivated the virus, while both the 
normal plasma and serum control animals became paralyzed on the 
9th day. 
Since  the  experiments  of  certain  previous  investigators  and  the 
recent tests  of  Weyer, Park  and  Banzhaf  all indicate that  by the 
TABLE  IV 
Experiment 3.  Horse  5 Globulin 
No.  Date 
.1/18 
1/18 
1/18 
.1/18 
.1/18 
Material  tested 
Filtered  antipoliomyelific 
horse globulin 
Unfiltered antipoliomye- 
litic horse globulin 
Anfipoliomyelitic horse 
plasma 
Normal horse plasma 
A noul  Lt 
D. 1 
D. 1 
0.1 
D. 1 
Virus 
amount 
CC. 
0.2 
0.2 
0.2 
0.2 
0.2 
Reset 
No symptoms 
Typical poliomyelitis, 9 
days 
injection of poliomyelitic nervous tissues, an occasional horse may be 
made to develop inactivating substances for the virus effective in vitro, 
the tests which we have made may be regarded as confirmatory.  We 
proceeded,  therefore, to our next problems which related first, to the 
mechanism  of  the  inactivation  process,  and  second,  to  the  in  vivo 
effects of the antiserum. 
The next experiment deals with the question of the action of adsorb- 
ing bodies on the inactivating substances.  Andervont and Lewis (20) 
have  shown that  colloidal  particles,  such  as  aluminium hydroxide, 
kaolin,  and  India  ink,  adsorb  vaccine  virus  and thus  render  it  in- c.  P.  ~OADS  129 
effective on inoculation.  A simple test brought out the fact that the 
antipoliomyelitic horse serum contained precipitin for normal monkey 
brain proteins.  Hence equal amounts of the antipoliomyelitic horse 
globulin and 5  per  cent saline suspension of normal monkey brain 
were mixed and shaken for 2 hours, after which they were kept in a 
water bath at 37°C. for 2 hours and placed in the icebox over night. 
The  clear  fluid,  separated  by  centrifugalization,  was  pipetted  off. 
This fluid failed to give the precipitin reaction. 
Experiment 4.--2 •.L.D.  Of  the filtrate virus were mixed with 0.1  cc.  each of 
unfiltered antipoliomyelitic horse globulin absorbed and unabsorbed with normal 
monkey brain, controlled by a simple virus injection. 
TABLE  V 
Experiment 4.  Normal  Brain Absorption 
No.  Date 
A/29 
L1/29 
L1/29 
Material  tested 
Antipoliomyelific  horse  un- 
filtered globulin absorbed by 
normal brain 
Anfipoliomyelitic  horse  un- 
filtered  globulin unabsorbed 
Plain control 
~OU 
~'(~. 
).1 
Z1 
Vii 
Kin~ 
cd 
0. 
0. 
0. 
Result 
No symptoms 
Typical poliomye- 
litis, 7 days 
Comment.--As Table V shows, the monkeys injected intracerebrally 
with  the  globulin-virus mixtures  remained  symptomless,  while the 
control animal became paralyzed on the 7th day.  In other words, the 
inactivating  substances  contained  in  the  antipoliomyelitic  horse 
globulin were not removed by the absorption  with normal monkey 
brain, as carried out in the experiment. 
We turn now to what may be termed the crucial experiments, in 
which the antipoliomyelitic horse serum is compared in its effects with 
convalescent human  and  monkey poliomyelitic sera.  Weyer, Park 
and  Banzhaf,  as  well as  Neust~dter  and  Banzhaf,  have  described 
in vivo tests in monkeys in which the antipoliomyelific horse serum 
preparations  displayed protective and  therapeutic  properties.  The 130  HORSE  ANTIPOLIOMYELITIC  SERUM 
employment of  Pettit's  serum  for  therapeutic  purposes  in  man  is 
postulated  on  these  same  properties.  Especial  interest,  therefore, 
attaches to this class of experiments. 
The experience of this laboratory with experiments of this kind is 
considerable.  At  the  beginning the  virus  inoculations were  made 
intracerebrally,  obviously a  severe test for the protective or thera- 
peutic action of an antiserum.  Later, intracisternal injection of the 
virus was employed in order to avoid the traumatic effects of intra- 
cerebral injection.  More recently, intranasal instillation of virus has 
superseded the intracisternal method, as involving no trauma whatever 
and as employing the usual portal of entry of the virus in man. 
The observations of Flexner and Stewart (21) on the duration of the 
protective effects of  convalescent sera  when injected  intraspinally, 
which observations have been confirmed and extended by  ourselves 
(22),  indicate a noteworthy manner of approach towards solving the 
problem  of  the  nature  of the  inactivating substances in  the  anti- 
poliomyelitic horse sera.  For instance, it had been shown by Flexner 
and Stewart and by ourselves that when 2 cc. of convalescent human 
or monkey serum is injected intrathecally, it is effective for 4  days 
against a  subsequent intracerebral injection of virus; and we found 
that it is sometimes effective for 6 days against nasal instillation of 
the virus.  In the next experiment, antipoliomyelitic horse  globulin 
was substituted for the convalescent sera. 
Experiment 5.--Two series of animals were employed  in this experiment.  2 cc. 
of the antipoliomyelitic horse globulin was injected intraspinally by lumbar 
puncture, followed  4 days later by intracerebral injection of ! ~¢.L.D.  of virus. 
Comment.--As  Table VI indicates,  under  conditions in which con- 
valescent  human  and  monkey  sera  prevent  the  development  of 
experimental poliomyelitis, the antipoliomelitic horse globulin solution 
was without demonstrable effect.  The  two  sets  of tests  made  are 
consistent.  The monkeys given the intraspinal injections of serum 
exhibited symptoms of experimental poliomyelitis after the injection 
of virus in average incubation time.  Attention should be called to 
Monkey 2 (Table VI), in which the symptoms are described as being 
mild.  For the purposes of comparison, brief clinical descriptions are 
appended of the three monkeys employed in this series. c.  P.  RHOADS  131 
Macacus rhesus 1 received 2 cc. of unfiltered globulin fraction of antipoliomyelitic 
horse serum,  injected  into  the lumbar  subarachnoid space by means  of spinal 
puncture.  48 hours later the animal was inoculated intracerebrally with 0.1  cc. 
of fresh virus filtrate.  After an incubation period of 9 days, the animal presented 
partial paralysis of one arm and complete paralysis of both legs.  On the following 
day, complete paralysis of the extremities had set in, the respirations were shallow 
and rapid; the animal was etherized.  Autopsy disclosed typical lesions of polio- 
myelitis. 
TABLE VI 
Experiment 5.  Prophylactic Effect of Antipollomyelitic  Horse Globulin 
No.  Date 
Intraspinal  globulin* 
Result 
Inoculations 
Interval 
before 
inocula-  Virus  Route 
tion  filtrate 
cG. 
4 days  M.V.  Icer.  C). 1 
Type  Amount 
Antipoliomyelitic  2  Typical poliomyell 
horse unfiltered  tis,  9 days 
globulin 
"  2  4  "  "  "  0.1  Mild poliomyelitis, 
days 
Control  --  "  "  O. 1  Typical  poliomyeli 
tis, 10 days 
Antipoliomyelitic  2 
horse  unfiltered 
globulin 
~c  2 
"  2 
4 days  "  "  9.1  Typical  poliomyeli 
tis, 4 days 
4  " 
4  " 
9.1  Typical  poliomyeli 
tis, 3 days 
3.1  Typical  poliomyeli 
tis, 4 days 
* Injected by lumbar puncture. 
Macacus  rhesus 2.  The animal received exactly the same spinal injection of 
antipoliomyelitic globulin and intracerebral inoculation of fresh  filtrate  virus  as 
did Monkey 1.  7 days after inoculation, the animal displayed mild symptoms of 
illness  consisting of excitement,  fine tremor of the head,  and ruffled fur--char- 
acteristics of early experimental poliomyelitis.  The condition failed to progress 
further and the animal proved resistant to subsequent inoculation. 
Macacus  rhesus  3.  This  test  served as a  control for the two previously de- 132  HORSE  ANTIPOLION[YELITIC  SERUM 
scribed.  No globulin was injected, but the animal received the same intracerebral 
inoculation of active virus as did Monkeys 1 and 2.  On the 10th day after inocu- 
lation, a marked tremor was present,  with wild excitement, very marked ataxia, 
and weakness of the left arm.  The following day, prostration had set in and the 
monkey was etherized.  The lesions found were characteristic  of poliomyelitis. 
Experiment 6.--The next series of tests may be called therapeutic, in distinction 
from the immediately preceding tests, which may be called prophylactic.  In the 
therapeutic series, intranasal instillation of the virus was employed for inoculation, 
and intraspinal injection of the globulin solutions for treatment.  The series was 
controlled not only in the usual way, but with antidiphtheria globulin solution. 
This experiment can be given adequately in the form of a table (Table VII) which 
presents  all the salient facts. 
Comment.--This  test  is  informing.  The  antipoliomyelitic  horse 
globulin  given  intraspinaUy  to  three  monkeys,  3  days  after  nasal 
instillation  of  virus,  protected  one  animal  completely,  one  animal 
doubtfully (excitement  and  ruffled fur for 2  days),  and one  animal 
not at all.  Antidiphtheria globulin administered in the same manner 
seems  to  have  protected  both  monkeys  to  which  it  was  given,  as 
neither developed symptoms of any kind.  The precise interpretation 
of  the  experiment may be  in  doubt,  and  the  tests  call perhaps  for 
repetition  on  a  larger  scale.  The  markedly  inconstant  protective 
effects of the antipoliomyelitic horse globulin are, however, in sharp 
contrast  with  the  regular  effects  of  convalescent  sera  (22)  under 
similar conditions of experiment.  They do not agree wholly with the 
reported  statement  of  Weyer,  Park,  and  Banzhaf  (13)  that  the 
globulin  solution  injected  intraspinally  confers  immunity  of  con- 
siderable  duration  against  the  virus  instilled  into  the  nares.  We 
would suggest that the  wide differences between Weyer and  Park's 
experimental  results  and  those  we  have  secured  are  due,  not  to 
technical irregularities, but to the potency and certainty of pathogenic 
action of the strains of virus which were employed by us. 
Experiment 7.--A final set of tests was carried out to determine the effect of 
Berkefeld filtration on the globulin solutions.  The technique  employed was the 
usual one of in vitro neutralization.  The antipoliomyelitic  horse  globulin was 
found inactivating before filtration.  Antidiphtheria horse globulin was employed 
for the control  test.  The results  summarized  in Table VIII are  consistent-- 
Berkefeld  filtration  deprived  the  globulin  preparations  of  their  inactivating 
properties. C. P. RI~OADS  133 
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TABLE  VIII 
Experiment 7.  Effect  of Filtration 
No.  Da~ 
4/22 
4/22 
4/22 
4/22 
Material  tested  for 
neutralizing  power 
Antipoliomyclitic  horse 
globulin-filtered 
Control  diphtheria  horse 
globulin 
Amou.~' 
0.06 
0.06 
0.24 
0.06 
Virus Globuli: 
aPaoun  virus 
filtratt  ratio 
¢C. 
0.4  1:6 
0.1  1:2 
0.4  1:6 
0.1  1:2 
Result 
Typical poliomyelitis, 5 
days 
Typical poliomyelitis, 7 
days 
SUMMARY 
Through the kindness of Dr. W. H. Park we have been  enabled to 
study a  horse  antipoliom3;elitic serum.  This preparation has  been 
supplied us in three forms: citrated blood plasma, serum, and globulin 
concentrate. 
We have tested these preparations in vitro and in vivo for inactivat- 
ing or neutralizing or, to use perhaps a better term, antiviral  effects 
against a constant, potent, filtrate virus of poliomyelitis. 
The  preparations  exhibited these effects when  combined in  vitro. 
Their action in this respect appears to be greater and more constant 
than  that  found  by  Stewart  and  Haselbauer  for  the  Pettit  anti- 
poliomyelitic  horse serum. 
On the other hand, in vivo tests carried out by us were less successful. 
In comparison with the constancy of  action, under given conditions, 
of convalescent monkey and human sera, the  anfipoliomyelitic horse 
serum displayed striking irregularity, and certain preparations were 
devoid of protective power. 
The  precise  nature  of  the  inactivating  substances  in  the  horse 
antiserum  and  their  relation  to  the  corresponding  substances  in 
convalescent sera have still to be determined.  As far  as one absorp- 
tion test carried out by us indicates, precipitin does not play a major 
r61e in the inactivating process. c.  1,.  RI~OADS  135 
When an active globulin concentrate was filtered through Berkefeld 
candles, it lost  its in  vitro  inactivating power.  This  is not  true  of 
convalescent sera in the native state.  No tests  have,  however, been 
made with globulin concentrates from such sera. 
The experiments described in this paper raise the question whether, 
therapeutically  considered, the antipoliomyelitic horse serum should 
be regarded as an exact equivalent of, and hence employed as a  perfect 
substitute  for,  convalescent  serum.  This  question  can  only  be 
answered by further experiment and observation. 
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